Melasma in Latin America: Options for therapy and treatment algorithm

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 7, 2009, Pages 760-772

  Cestari, T ^a   Arellano, I ^b   Hexsel, D ^c   Ortonne, J P ^d  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b HOSPITAL GENERAL DE MÉXICO   (Mexico)

^c UNIVERSITY OF PASSO FUNDO   (Brazil)

^d UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

Evidence based medicine; Hispanic; Hydroquinone; Melasma; Quality of life; Triple combination cream

Indexed keywords

AZELAIC ACID; CORTICOSTEROID; DEXAMETHASONE; FLUOCINOLONE ACETONIDE; GLYCOLIC ACID; HYDROCORTISONE; HYDROQUINONE; KOJIC ACID; MEQUINOL; MEQUINOL PLUS RETINOIC ACID; PLACEBO; RESORCINOL DERIVATIVE; RETINOIC ACID; RETINOID; RUCINOL; UNCLASSIFIED DRUG;

ACNE; ALGORITHM; ASTHMA; BURNING SENSATION; CHLOASMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; HUMAN; HYPERPIGMENTATION; HYPERTRICHOSIS; LOW LEVEL LASER THERAPY; OCHRONOSIS; PERIORAL DERMATITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRURITUS; REVIEW; ROSACEA; SKIN ALLERGY; SKIN ATROPHY; SKIN IRRITATION; SOUTH AND CENTRAL AMERICA; SUN EXPOSURE; TELANGIECTASIA; UNSPECIFIED SIDE EFFECT; VITILIGO;

ALGORITHMS; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; FLUOCINOLONE ACETONIDE; HUMANS; HYDROQUINONES; LATIN AMERICA; MELANOSIS; QUALITY OF LIFE; TRETINOIN;

EID: 66749115980     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2009.03251.x     Document Type: Review

References (85)

1. Halder RM, Richards GM. Management of dyschromia in ethnic skin. Dermatol Ther 2004 17 : 151 157.
2. Gupta AK, Gover MD, Nouri K, Taylor S. The treatment of melasma: a review of clinical trials. J Am Acad Dermatol 2006 55 : 1048 1065. (Pubitemid 44716465)
3. Sanchez NP, Pathak MA, Sato S et al. Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study. J Am Acad Dermatol 1981 4 : 698 710. (Pubitemid 11038002)
4. Kang WH, Yoon KH, Lee ES et al. Melasma: histopathological characteristics in 56 Korean patients. Br J Dermatol 2002 146 : 228 237. (Pubitemid 34264392)
5. Vazquez M, Maldonado H, Benmaman C, Sanchez JL. Melasma in men: a clinical and histologic study. Int J Dermatol 1988 27 : 25 27. (Pubitemid 18061166)
6. Sodhi VK, Sausker WF. Dermatoses of pregnancy. Am Fam Physician 1988 37 : 131 138. (Pubitemid 18072721)
7. Resnik S. Melasma induced by oral contraceptive drug. JAMA 1967 199 : 95 99.
8. Lufti RJ, Fridmanis M, Misiunas AL et al. Association of melasma with thyroid autoimmunity and other thyroidal abnormalities and their relationship to the origin of the melasma. J Clin Endocrinol Metab 1985 61 : 8 31.
9. Perez M, Sanchez JL, Aguilo F. Endocrinologic profile of patients with idiopathic melasma. J Invest Dermatol 1983 81 : 543 545. (Pubitemid 14202316)
10. Grimes PE. Melasma: etiologic and therapeutic considerations. Arch Dermatol 1995 131 : 1453 1457.
11. Wolf R, Wolf D, Tamir A, Politi Y. Melasma: a mask of stress. Br J Dermatol 1991 125 : 192 193.
12. Pathak MA, Fitzpatrick TB, Kraus EW. Usefulness of retinoic acid in the treatment of melasma. J Am Acad Dermatol 1986 15 : 894 899. (Pubitemid 17170795)
13. Taylor S. Epidemiology of skin diseases in ethnic populations. Dermatol Clin 2003 21 : 601 607. (Pubitemid 38005075)
14. Bonilla C, Parra EJ, Pfaff CL et al. Admixture in the Hispanics of the San Luis Valley, Colorado, and its implications for complex trait gene mapping. Ann Hum Genet 2004 68 : 139 153. (Pubitemid 38379845)
15. Hexsel D, Arellano I, Rendon M. Ethnic considerations in the treatment of Hispanic and Latin-American patients with hyperpigmentation. Br J Dermatol 2006 156 (Suppl. 1 7 12. (Pubitemid 44809123)
16. Henríquez H, Moraga M, Llop E et al. Caracterización genético molecular de habitantes de Caleta Paposo, último reducto Chango en Chile. Rev Méd Chile 2004 132 : 663 672.
17. Etcheverry R. Human races and hemato-sero-anthropology: origins of Chilean natives and natives from Easter Island in the context of human races. Rev Méd Chile 1997 125 : 1073 1081.
18. Failmezger C. Incidence of skin disease in Cuzco, Peru. Int J Derm 1992 31 : 560 561.
19. Sanchez MR. Cutaneous diseases in Latinos. Dermatol Clin 2003 21 : 689 697. (Pubitemid 38005083)
20. Hexsel D. A review of Clinical Data from 100 Brazilian Patients Affected by Melasma. Poster Presented at AAD, Chicago, IL, 2005.
21. Hexsel D, Rodrigues TC, Zechmeister do Prado D, Lima MM. Melasma in Brazilian Pregnant Women: Study of Cases. Poster presented at AAD, Washington D.C. USA, 2007.
22. Kimborough-Green CK, Griffiths CE, Finkel LJ et al. Topical retinoic acid (tretinoin) for melasma in black patients. Arch Dermatol 1994 130 : 727 733.
23. Menter A. Rationale for the use of topical corticosteroids in melasma. J Drugs Dermatol 2004 3 : 169 174.
24. Sanclemente G, Hernandez G, Gaviria A et al. Preocupantes Índices de Radiación Ultravioleta en Medellín y el Oriente Antioqueño (Colombia). Poster presented at the XXIV Reunión Anual de Dermatólogos Latinoamericanos (RADLA), Buenos Aires, Argentina, 2005.
25. Piamphongsant T. Treatment of melasma: a review with personal experience. Int J Dermatol 1998 37 : 897 903. (Pubitemid 29012777)
26. Kauh YC, Zachian TF. Melasma. Adv Exp Med Biol 1999 455 : 491 499. (Pubitemid 32187499)
27. Ennes SBP, Paschoalick RC, Mora M. A double-blind trial, comparative, placebo-controlled study of the efficacy and tolerability of 4% hydroquinone as a depigmenting agent in melasma. J Dermatol Treat 2000 11 : 173 179.
28. Cestari TF, Hassun K, Sittart A, de Lourdes Viegas M. A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma. J Cosmet Dermatol 2007 6 : 36 39. (Pubitemid 46390328)
29. Garcia A, Fulton JE Jr. The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions. Dermatol Surg 1996 22 : 443 447. (Pubitemid 26153095)
30. Kang WH, Chun SC, Lee S. Intermittent therapy for melasma in Asian patients with combined topical agents (retinoic acid, hydroquinone and hydrocortisone): clinical and histological studies. Dermatol 1998 25 : 587 596. (Pubitemid 28484052)
31. Guevara IL, Pandya AG. Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma. Int J Dermatol 2003 42 : 966 972. (Pubitemid 38004473)
32. Haddad AL. A clinical, prospective, randomized, double-blind trial comparing skin whitening complex with hydroquinone vs. placebo in the treatment of melasma. Int J Dermatol 2003 42 : 153 156. (Pubitemid 41709845)
33. Khemis A, Kaiafa A, Queille-Roussel C et al. Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial. Br J Dermatol 2007 156 : 997 1004. (Pubitemid 46642853)
34. Kakita LS, Lowe NJ. Azelaic acid and glycolic acid combination therapy for facial hyperpigmentation in darker-skinned patients: a clinical comparison with hydroquinone. Clin Ther 1998 20 : 960 970. (Pubitemid 28535731)
35. Azulay-Abulafia L, Tanaka R, Spinelli L et al. Topic treatment of melasma with monomethyl ether of hydroquinone (MMEH). Efficacy clinic study. Revista Brasileira Med 2003 60 : 595 600. (Pubitemid 37214341)
36. Verallo-Rowell VM, Verallo V, Graupe K et al. Double-blind comparison of azelaic acid and hydroquinone in the treatment of melasma. Acta Derm Venereol (Suppl.)(Stockh) 1989 143 : 58 61. (Pubitemid 19172051)
37. Yoshimura K, Kiyonori H, Aoyama T, Iga T. Experience with a strong bleaching treatment for skin hyperpigmentation in Orientals. Plast Reconstr Surg 2000 105 : 1097 1108. (Pubitemid 30158819)
38. Balina LM, Graupe K. The treatment of melasma. 20% azelaic acid versus 4% hydroquinone cream. Int J Dermatol 1991 30 : 893 895.
39. Taylor SC, Torok H, Jones T et al. Efficacy and safety of a new triple-combination agent for the treatment of facial melasma. Cutis 2003 72 : 67 72. (Pubitemid 37229761)
40. Torok H. A large 12 month extension study of an 8-week trial to evaluate the safety and efficacy of triple combination (TC) cream in melasma patients previously treated with TC cream or one of its dyads. J Drugs Dermatol 2005 4 : 592 597.
41. Grimes PE, Kell AP, Willis I. Community based trial of triple-combination agent for the treatment of melasma. Cutis 2006 77 : 177 184.
42. Macedo FS, Kaminsky KK, Bagatin E et al. Melasma: a comparative study of the combination of glycolic acid and hydroquinone in association with glycolic acid peelings. Med Cutan Iber Lat Am 2006 34 : 11 16. (Pubitemid 46768547)
43. Lim JT, Tham SN. Glycolic acid peels in the treatment of melasma among Asian women. Dermatol Surg 1997 23 : 177 179. (Pubitemid 27200622)
44. Sarkar R, Kaur C, Bhalla M, Kanwar AJ. The combination of glycolic acid peels with a topical regimen in the treatment of melasma in dark-skinned patients: a comparative study. Dermatol Surg 2002 28 : 828 832.
45. Erbil H, Sezer E, Taştan B et al. Efficacy and safety of serial glycolic acid peels and a topical regimen in the treatment of recalcitrant melasma. J Dermatol 2007 4 : 25 30. (Pubitemid 46005953)
46. Hurley ME, Guevara IL, Gonzales RM, Pandya AG. Efficacy of glycolic acid peels in the treatment of melasma. Arch Dermatol 2002 138 : 1578 1582. (Pubitemid 35453470)
47. Chun EY, Lee JB, Lee KH. Focal trichloroacetic acid peel method for benign pigmented lesions in dark-skinned patients. Dermatol Surg 2004 30 : 512 516. (Pubitemid 38529590)
48. Khunger N, Sakar R, Jain RK. Tretinoin peels versus glycolic acid peels in the treatment of melasma in dark-skinned patients. Dermatol Surg 2004 30 : 756 760. (Pubitemid 38657969)
49. Sharquie K, Al-Tikreety MM, Al-Mashhadani SA. Lactic acid chemical peels as a new therapeutic modality in melasma in comparison to Jessner's solution chemical peels. Dermatol Surg 2006 32 : 1429 1436. (Pubitemid 44934890)
50. Cotellessa C, Peris K, Onorati MT et al. The use of chemical peelings in the treatment of different cutaneous hyperpigmentations. Derm Surg 1999 25 : 450 454. (Pubitemid 29279585)
51. Kunachak S, Leelaudomlipi P, Wongwaisayawan S. Dermabrasion: a curative treatment for melasma. Aesth Plast Surg 2001 25 : 114 117. (Pubitemid 32374025)
52. Wang CC, Hui CY, Sue YM et al. Intense pulsed light for the treatment of refractory melasma in Asian persons. Dermatol Surg 2004 30 : 1196 1200.
53. Manalato RMP, Alster T. Erbium: YAG laser resurfacing for refractory melasma. Dermatol Surg 1999 25 : 121 123. (Pubitemid 30195951)
54. Rokhsar C, Fitzpatrick R. The treatment of melasma with fractional photothermolysis: a pilot study. Dermatol Surg 2005 31 : 1645 1650. (Pubitemid 43031166)
55. Cotellessa C, Peris K, Fargnoli MC et al. Microabrasion versus microabrasion followed by 15% trichloroacetic acid for treatment of cutaneous hyperpigmentations in adult females. Dermatol Surg 2003 29 : 352 356. (Pubitemid 36417447)
56. Rendon M. Utilising combination therapy to optimise melasma outcomes. J Drug Dermatol 2004 3 : 527 534.
57. Penney NS. Ochronosis: life pigmentation from bleaching creams. Arch Derm 1985 121 : 1239 1240.
58. Nair X, Tramposch KM. The Yucatan miniature swine as an in vivo model for screening skin depigmentation. J Dermatol Sci 1991 2 : 428 433.
59. Rendon M, Berneburg M, Arellano I, Picardo M. Treatment of melasma. J Am Acad Derm 2006 : S272 81.
60. Leenutaphong V, Nettakul A, Rattanasuwon P. Topical isotretinoin for melasma in Thai patients: a vehicle-controlled clinical trial. J Med Assoc Thai 1999 82 : 868 875.
61. Ortonne JP. Retinoid therapy of pigmentary disorders. Dermatol Ther 2006 19 : 280 288.
62. Kligman AM, Willis I. A new formula for depigmenting human skin. Arch Dermatol 1975 111 : 40 48.
63. Nazarro Porro M, Passi S. Identification of tyrosinase inhibitors in cultures of pityrosporum. J Invest Dermatol 1978 71 : 205 208. (Pubitemid 9082184)
64. Sarkar R, Bhalla M, Kanwar AJ. A comparative study of 20% azelaic acid cream monotherapy versus a sequential therapy in the treatment of melasma. Dermatology 2000 205 : 249 254.
65. De Arocha JR. Nuevas opciones en al tratamiento del melasma. Dermatologia Venezolana 2003 41 : 11 14.
66. Picardo M, Carrera M. New and experimental treatments of cloasma and other hypermelanoses. Dermatol Clin 2007 25 : 353 362. (Pubitemid 47088898)
67. Keeling J, Cardona L, Benitez A et al. Mequinol 2%/Tretinoin 0.01% topical solution for the treatment of melasma in men: a case series and review of the literature. Cutis 2008 81 : 179 183.
68. Torok HM, Jones T, Rich P et al. Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma. Cutis 2005 75 : 57 62. (Pubitemid 40223103)
69. Balkrishnan R, Kelly AP, McMichael A, Torok H. Improved quality of life with effective treatment of facial melasma: the Pigment trial. J Drugs Dermatol 2004 3 : 377 381.
70. Cestari TF, Hexsel D, Viegas ML et al. Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the MelasQoL-BP study and improvement of QoL of melasma patients after triple combination therapy. Br J Dermatol 2007 156 (Suppl. 1 13 20. (Pubitemid 44809124)
71. Grimes PE. The safety and efficacy of salicylic acid and chemical peels in darker racial-ethnic groups. Dermatol Surg 1999 25 : 18 22. (Pubitemid 29242727)
72. Lawrence N, Cox SE, Brody HJ. Treatment of melasma with Jessner's solution versus glycolic acid: a comparison of clinical efficacy and evaluation of the predictive ability of Wood's light examination. J Am Acad Dermatol 1997 36 : 589 593. (Pubitemid 27164492)
73. Hernández-Perez E, Ibiett EV. Gross and microscopic findings in patients undergoing microdermabrasion for facial rejuvenation. Dermatol Surg 2001 27 : 637 648.
74. Freedman BM, Rueda-Pedraza E, Waddell SP. The epidermal and dermal changes associated with microdermabrasion. Dermatol Surg 2001 27 : 1031 1033.
75. 2 laser and Q-switched alexandrite laser compared with Q-switched alexandrite alone for refractory melasma: split-face design. Dermatol Surg 2003 29 : 59 74.
76. Taylor CR, Anderson RR. Ineffective treatment of refractory melasma and hyperpigmentation by Q-switched ruby laser. J Dermatol Surg Oncol 1994 20 : 592 597. (Pubitemid 24292440)
77. Rahman Z, Alam M, Dover JS. Fractional laser treatment for pigmentation and texture improvement. Skin Therapy Lett 2006 11 : 7 11.
78. Vazquez M, Sanchez JL. The efficacy of a broad-spectrum sunscreen in the treatment of melasma. J Dermatol Treat 1996 7 : 235 237.
79. Piquero-Martin J. Rothe de Arocha J, Beniamini Loker D. Studio clinico doble ciego en al tratamiento del melasma entre acido azelaico versus hidroquinona. Med Cut Iber Lat Am 1988 16 : 511 514.
80. Balkrishnan R, McMichael AJ, Camaho FT et al. Development and validation of a health-related quality of life instrument for women with melasma. Br J Dermatol 2003 149 : 572 577. (Pubitemid 37281590)
81. Arellano I, Leon G, Luna C et al. Quality of life in Mexican patients with melasma. Cosmetic Dermatol 2006 19 : 343 345. (Pubitemid 46100070)
82. Pawaskar MD, Parikh P, Markowski T et al. Melasma and its impact on health-related quality of life in Hispanic women. J Dermatol Treat 2007 18 : 5 9. (Pubitemid 46410634)
83. Sanclemente G, Herane MI, The National Tri-Luma Group of Experts et al. Efficacy and Safety in the use of Triple Combination Cream to Treat Melasma in Latin Americans. Poster presented at the WCD, Buenos Aires, Argentina, 2007.
84. Roberts WE. Chemical peeling in ethnic/dark skin. Dematol Ther 2004 17 : 196 205. (Pubitemid 38656912)
85. Arellano-Mendoza I, Arias-Gomez I, Barba-Gomez JF et al. Consensus of the Mexican Working Group for the Study of Pigmentary Disorders. Dermatologica 2007 5 : 112 122.